This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0009922808315211v1 47/7/659    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Google Scholar Articles by Parekh, D. Articles by Levsky, M. E. PubMed PubMed Citation Articles by Parekh, D. Articles by Levsky, M. E. Social Bookmarking                   What's this?

Transdermal Patch Medication Delivery Systems and Pediatric Poisonings, 2002-2006

^* To whom correspondence should be addressed. E-mail: michael.adam.miller{at}us.army.mil.

	Abstract

Transdermal drug delivery systems are an increasingly popular method of medication delivery containing large quantities of medication and presenting new opportunities for toxicity. To provide a description of exposures to transdermal medications in a pediatric population, we studied exposures in individuals less than 12 years of age. This is a retrospective database study in which the Texas Poison Center Network database from 2002 to 2006 was reviewed. In all, 336 poison control center records of patch exposures over the 5-year period were identified. Of those, 110 cases involved children less than 12 years old. A majority of cases resulted in no significant clinical effects. One death resulted from opioid toxicity. Although a majority of patch exposures in children less than 12 years of age resulted in no significant clinical toxicity, practitioners and the public must be made aware of the available patch-based medications and their potential for toxicity in children.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?